NCT00034762

Data

{
  "briefSummary": "The purpose of this study is to evaluate the efficacy and safety of risperidone compared with placebo in the treatment of psychotic symptoms in patients with Alzheimer's disease",
  "completionDate": "2003-01",
  "conditions": [
    "Dementia",
    "Alzheimer Disease",
    "Mental Disorders"
  ],
  "enrollmentCount": 473,
  "enrollmentType": "ACTUAL",
  "nctId": "NCT00034762",
  "phase": "PHASE3",
  "sponsorId": "johnson-johnson-pharmaceutical-research-development-l-l-c",
  "startDate": "2000-12",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Efficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer's Disease.",
  "url": "https://clinicaltrials.gov/study/NCT00034762"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version